Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • SocialBoost
  • Rooms
    • MediaRoom
    • ESG Rooms
  • AI Tools
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • Cision Communications Cloud®
  • AI Tools
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

Microbiome and Diabetes: Sick or healthy? Bacterial Metabolism Tells us Which - and Why


News provided by

University of Luxembourg

12 Oct, 2016, 06:30 GMT

Share this article

Share toX

Share this article

Share toX

This image opens in the lightbox
Patient measuring his blood sugar. The MUST study focused on individuals who have already suffered from type 1 diabetes for several years. (PRNewsFoto/University of Luxembourg)
This image opens in the lightbox
Prof. Paul Wilmes, Head of the LCSB Ecosystems Biology Group, study leader. (PRNewsFoto/University of Luxembourg)

ESCH-SUR-ALZETTE, Luxembourg, October 12, 2016 /PRNewswire/ --

The human gut is a complex ecosystem: Countless bacteria colonise it and help us to digest our food. Scientists from the Luxembourg Centre for Systems Biomedicine (LCSB) of the University of Luxembourg in collaboration with the IBBL (Integrated BioBank of Luxembourg), the Centre Hospitalier de Luxembourg and the Centre Hospitalier Emile Mayrisch have developed a way to study this ecosystem - the microbiome of the gut - in unprecedented detail: Their new approach allows examination of the genetic potential of the bacteria by decoding their DNA as well as assessing their activity by sequencing RNA, the molecules that are first formed upon transcription of the DNA.

     (Photo: http://photos.prnewswire.com/prnh/20161011/427429 )

     (Photo: http://photos.prnewswire.com/prnh/20161011/427430 )

They can also identify the proteins that are subsequently synthesised which in turn then catalyse metabolic reactions. "For the first time, we can now observe what happens simultaneously at the three levels of DNA, RNA and proteins within the microbial communities of the gut," says Prof. Paul Wilmes, head of the LCSB Ecosystems Biology Group, who led the study. "This is important for us to better understand diseases such as diabetes, which the gut microbiome may have an effect on." The researchers have discovered, for example, that the composition of the gut microbiota hardly differs between patients with diabetes and healthy individuals. On the other hand, the genes which are switched on or off by the resident bacteria can be very different. The researchers publish their findings today in the renowned British journal "Nature Microbiology" (DOI: 10.1038/NMICROBIOL.2016.180).

The MUST study (Diabetes multiplex family study) focused on individuals who have already suffered from type 1 diabetes for several years, and who had provided stool samples to the IBBL - an essential partner of the study. "We studied the bacteria in the stool samples from these people," says Dr. Anna Heintz-Buschart, first author of the paper. "We also analysed stool samples from healthy close relatives of the patients with diabetes." The researchers discovered that there is much less of a difference in bacterial species composition between people with and without diabetes than had long been believed. "However," Heintz-Buschart continues, "there are clear differences in what the bacteria do."

In type 1 diabetes, these differences presumably arise when the body's immune system attacks its own insulin-producing cells in the pancreas. The resulting damage can radically upset the composition of digestive juices. "The gut bacteria have to adapt to the changes in their environment," Heintz-Buschart explains. "They do this by adjusting their metabolism, or in other words they change the amounts of proteins or vitamins they produce, such as thiamine. What matters here is that a change in the body's thiamine levels can exacerbate the course of the disease." The once beneficial bacteria thus become a health risk and can worsen the sufferer's condition.

Such precise descriptions of disease-related changes in the microbiome and insights into their functional effects in the body were not possible until now, stresses Paul Wilmes: "While we had been able to determine the species composition in the gut ecosystem by conventional DNA analyses, we were in the dark as to what was actually going on there at a given point in time. To use the analogy of human society: we were able to carry out a census of different individuals without knowing what they might do as a profession. Now we know who does what and when." The breakthrough came when they combined different analytical techniques: "We looked at genomic, transcriptomic and proteomic information together for the first time, meaning we simultaneously studied the DNA, RNA and proteins of the microbiome. Thus, we are now able to study which genes are transcribed and what proteins are produced at a given point in time. This simultaneous study at the three levels gives us an entirely new picture of the functional processes occurring in the gut, for example in relation to metabolism."

The medical professionals with whom Wilmes and his team collaborated see great hope in the new research approach. This includes Prof. Dr. Carine de Beaufort, who conducts research and treats patients at the LCSB and at the Centre Hospitalier de Luxembourg. She was instrumental in finding families in which healthy and sick members were willing to participate in the study. "We expect these studies to help us identify biomarkers," she says. "These are molecules, such as proteins, that are produced or whose body levels change in the early stages of a diabetic condition. Such biomarkers would make diagnosis easier, so that we could already take preventive or therapeutic action at a very early stage."

In order to drive the search for these biomarkers, the study must go on, Paul Wilmes asserts. "We now wish to work together with families who have children with early forms of diabetes," he says. "For young people especially, it is important to detect indicators of the disease as early as possible. After all, the earlier doctors can intervene, the better they can assure a life with as few limitations as possible." Wilmes envisages detailed mechanistic studies that will give us a better understanding of the complex functions of the microbiome: "This way, we can learn how functional differences in, say, the biosynthesis of the vitamin thiamine by the gut microbiome relate to type 1 diabetes. Studies like MUST are crucial for this, as hypothesis generators."

The MUST project was carried out in collaboration between groups at the Luxembourg Centre for Systems Biomedicine, the IBBL, the Centre Hospitalier de Luxembourg and the Centre Hospitalier Emile Mayrisch. The project has been initiated within the Personalised Medicine Consortium and received financial support from the IBBL and the Luxembourg National Research Fund's ATTRACT, CORE, INTER and AFR funding programmes.

Notes to the editor: 

Bibliography: 

Anna Heintz-Buschart, Patrick May, Cédric C. Laczny, Laura A. Lebrun, Camille Bellora, Abhimanyu Krishna, Linda Wampach, Jochen G. Schneider, Angela Hogan, Carine de Beaufort and Paul Wilmes: Integrated multi-omics of the human gut microbiome in a case study of familial type 1 diabetes. Nature Microbiology

For further information, please contact: Ass. Prof. Dr. Paul Wilmes, E. paul.wilmes@uni.lu , T. +352-46-66-44-6188

Thomas Klein
Science Editor
Communications Department

UNIVERSITÉ DU LUXEMBOURG

CAMPUS BELVAL
2, avenue de l'Université
L-4365 Esch-sur-Alzette
T +352-46-66-44-5148
F +352-46-66-44-3-6114
thomas.klein@uni.lu / http://www.uni.lu

Modal title

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.